Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue growth | | | | | | | | -100.0% |
Cost of goods sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross margin | | | | | | | | |
Selling, general and administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT margin | | | | | | | | |
Pre-tax income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax rate | | | | | | | | |
Net income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net margin | | | | | | | | |
|
Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Shares outstanding (diluted) | 1,053 | 2,424 | 807 | 2,437 | 811 | 804 | 802 | 842 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|